Enliven Therapeutics (ELVN.US) Shareholder Detail - Holdings History & Trades | Longbridge

TR

T. Rowe Price Group, Inc.

BuySellPriceUnit: Shares

Holdings History

Date
Latest	4.21%	+3.11M	4.37%	3.20M	06/30/2026
Q2 2026	4.21%	+3.11M	4.38%	3.20M	06/30/2026
Q1 2026	0.12%	+73.95K	0.16%	97.75K	03/31/2026
Q4 2025	0.35%	-207.50K	0.04%	23.80K	12/31/2025
Q3 2025	0.50%	-296.95K	0.39%	231.30K	09/30/2025
Q2 2025	0.86%	+512.09K	0.89%	528.25K	06/30/2025
Q1 2025	<0.01%	+2.53K	0.03%	16.16K	03/31/2025
Q4 2024	<0.01%	+1.98K	0.03%	13.63K	12/31/2024
Q3 2024	<0.01%	+440.00	0.02%	11.65K	09/30/2024
Q2 2024	0.02%	+9.71K	0.02%	11.21K	06/30/2024
Q1 2024	<0.01%	+252.00	<0.01%	1.50K	03/31/2024
Q4 2023	<0.01%	+0	<0.01%	1.25K	12/31/2023
Q3 2023	<0.01%	+102.00	<0.01%	1.25K	09/30/2023
Q2 2023	--	+1.15K	<0.01%	1.15K	06/30/2023